Kelsey Stephen Michael sold RVMD
March 17, 2026 · Form 4 insider transaction
Kelsey Stephen Michael sold 4,302 shares of Revolution Medicines, Inc. at $99.48 per share, a transaction worth $428.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,302
Price
$99.48
Total value
$428.0K
InsiderKelsey Stephen Michael
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after295,398
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Includes 84,250 RSUs.